The National Association of Board of Pharmacy (NABP) is urging members of Congress to support federal programs to deal with the COVID-19 outbreak as well as an epidemic of opioid drug abuse in the country the virus might be fueling. Read More »

PANTHERx® Rare Pharmacy announces that it has been selected by Ultragenyx Pharmaceutical as a limited distribution partner for new drug DOJOLVI™ (triheptanoin). DOJOLVI™ (a highly purified, pharmaceutical-grade, synthetic seven carbon fatty acid triglyceride) is a specially designed synthetic triglyceride compound, which was developed to treat patients with long-chain fatty acid oxidation disorders (LC-FAOD). Read More »

A study facilitated by Vizient, Inc. and recently published in the Journal of American Medical Association Internal Medicine yielded new insights about patients with presumed penicillin allergies. Read More »

Hospital pharmacists are becoming more involved in patient care and are embracing new technology, a new study found. Read More »

One of the fastest-growing pharmaceuticals companies in the country, headquartered in Lexington County, today announced several major expansion and investment projects. Read More »

The conference will take place virtually in conjunction with the eighth NASP Annual Meeting & Expo Virtual Experience Read More »

Thousands of Americans suffer from Chronic Obstructive Pulmonary Disease (COPD), but new recommendations from a pair of health organizations may help ease their discomfort. Read More »

Six months into the COVID-19 pandemic, pharmaceutical companies join forces to develop drugs and vaccines to eliminate the virus. Read More »

New Site Features More Information, Improved User Experience Read More »

Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET Read More »

Going to the emergency room can be stressful and scary for patients especially if they are over the age of 50. Read More »

Several pharmaceutical companies are staying vigilant in their commitment to finding proper treatments and vaccine research and development (R&D) related to COVID-19, according to PhRMA. Read More »

Johns Hopkins researchers find that standard PTSD treatment does not cause drug use relapse. Read More »

In a letter delivered to the majority and minority leaders of Congress, the American Pharmacists Association requested immediate action to address the growing need to expand COVID-19 testing and immunization services by providing all pharmacists with temporary provider status in Medicare Part B. Read More »

MHA Study Reveals Member Medication Adherence Rates for Long-Term Care Pharmacies Serving Skilled Nursing and Assisted Living Patients Read More »

To control the opioid crisis, states are developing programs within the health care system to fight opioid use disorder (OUD) by increasing both the access to and quality of available treatment for those afflicted. Read More »

Signs Exclusive U.S. Distribution Agreement with Novitium Pharma Read More »

Agenus Inc. (NASDAQ: AGEN), an immuno-oncology (I-O) company with an extensive pipeline of agents designed to activate immune response to cancers, announced the closing of a $20 million equity investment, at $4.03 per share, by Betta Pharmaceuticals (SZ300558) bringing the total received to $35M. Read More »

The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »

A recent report by the biopharmaceutical industry shows that there are over 400 medicines and vaccines in development to treat infectious diseases, including COVID-19, according to a news release by PhRMA. Read More »